181 related articles for article (PubMed ID: 38169715)
1. Enhanced central sympathetic tone induces heart failure with preserved ejection fraction (HFpEF) in rats.
Nandi SS; Katsurada K; Moulton MJ; Zheng H; Patel KP
Front Physiol; 2023; 14():1277065. PubMed ID: 38169715
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a robust mouse model of heart failure with preserved ejection fraction.
Matsiukevich D; Kovacs A; Li T; Kokkonen-Simon K; Matkovich SJ; Oladipupo SS; Ornitz DM
Am J Physiol Heart Circ Physiol; 2023 Aug; 325(2):H203-H231. PubMed ID: 37204871
[TBL] [Abstract][Full Text] [Related]
3. Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction.
Chang D; Xu TT; Zhang SJ; Cai Y; Min SD; Zhao Z; Lu CQ; Wang YC; Ju S
Exp Biol Med (Maywood); 2021 Dec; 246(23):2511-2521. PubMed ID: 34342551
[TBL] [Abstract][Full Text] [Related]
4. Cardiac diastolic and autonomic dysfunction are aggravated by central chemoreflex activation in heart failure with preserved ejection fraction rats.
Toledo C; Andrade DC; Lucero C; Arce-Alvarez A; Díaz HS; Aliaga V; Schultz HD; Marcus NJ; Manríquez M; Faúndez M; Del Rio R
J Physiol; 2017 Apr; 595(8):2479-2495. PubMed ID: 28181258
[TBL] [Abstract][Full Text] [Related]
5. Experimental cardiac radiation exposure induces ventricular diastolic dysfunction with preserved ejection fraction.
Saiki H; Moulay G; Guenzel AJ; Liu W; Decklever TD; Classic KL; Pham L; Chen HH; Burnett JC; Russell SJ; Redfield MM
Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H392-H407. PubMed ID: 28550173
[TBL] [Abstract][Full Text] [Related]
6. A mouse model of heart failure with preserved ejection fraction due to chronic infusion of a low subpressor dose of angiotensin II.
Regan JA; Mauro AG; Carbone S; Marchetti C; Gill R; Mezzaroma E; Valle Raleigh J; Salloum FN; Van Tassell BW; Abbate A; Toldo S
Am J Physiol Heart Circ Physiol; 2015 Sep; 309(5):H771-8. PubMed ID: 26188021
[TBL] [Abstract][Full Text] [Related]
7. Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction.
Kasner M; Aleksandrov AS; Westermann D; Lassner D; Gross M; von Haehling S; Anker SD; Schultheiss HP; Tschöpe C
Int J Cardiol; 2013 Oct; 168(5):4652-7. PubMed ID: 23968714
[TBL] [Abstract][Full Text] [Related]
8. Chronic administration of angiotensin-(1-7) attenuates pressure-overload left ventricular hypertrophy and fibrosis in rats.
Wang LJ; He JG; Ma H; Cai YM; Liao XX; Zeng WT; Liu J; Wang LC
Di Yi Jun Yi Da Xue Xue Bao; 2005 May; 25(5):481-7. PubMed ID: 15897115
[TBL] [Abstract][Full Text] [Related]
9. [Role of ACE2-Ang (1-7)-Mas receptor axis in heart failure with preserved ejection fraction with hypertension].
Yu J; Wu Y; Zhang Y; Zhang L; Ma Q; Luo X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Jul; 43(7):738-746. PubMed ID: 30124209
[TBL] [Abstract][Full Text] [Related]
10. Cellular mechanisms of metabolic syndrome-related atrial decompensation in a rat model of HFpEF.
Hohendanner F; Bode D; Primessnig U; Guthof T; Doerr R; Jeuthe S; Reimers S; Zhang K; Bach D; Wakula P; Pieske BM; Heinzel FR
J Mol Cell Cardiol; 2018 Feb; 115():10-19. PubMed ID: 29289652
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of Na
Primessnig U; Bracic T; Levijoki J; Otsomaa L; Pollesello P; Falcke M; Pieske B; Heinzel FR
Eur J Heart Fail; 2019 Dec; 21(12):1543-1552. PubMed ID: 31762174
[TBL] [Abstract][Full Text] [Related]
12. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
Kraigher-Krainer E; Shah AM; Gupta DK; Santos A; Claggett B; Pieske B; Zile MR; Voors AA; Lefkowitz MP; Packer M; McMurray JJ; Solomon SD;
J Am Coll Cardiol; 2014 Feb; 63(5):447-56. PubMed ID: 24184245
[TBL] [Abstract][Full Text] [Related]
13. Effects and mechanism of Compound Qidan Formula on rats with HFpEF induced by hypertension and diabetes mellitus based on Ang Ⅱ/TGF-β1/Smads signaling pathway.
Yuan P; Liu J; Xiong S; Yang L; Guan J; Dong G; Shi D
J Ethnopharmacol; 2023 Sep; 313():116558. PubMed ID: 37116729
[TBL] [Abstract][Full Text] [Related]
14. Cardiac reverse remodeling in a mouse model with many phenotypical features of heart failure with preserved ejection fraction: effects of modifying lifestyle.
Aidara ML; Walsh-Wilkinson É; Thibodeau SÈ; Labbé EA; Morin-Grandmont A; Gagnon G; Boudreau DK; Arsenault M; Bossé Y; Couët J
Am J Physiol Heart Circ Physiol; 2024 Apr; 326(4):H1017-H1036. PubMed ID: 38363584
[TBL] [Abstract][Full Text] [Related]
15. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
Paulus WJ; Tschöpe C
J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
[TBL] [Abstract][Full Text] [Related]
16. Preload-corrected dynamic Starling mechanism in patients with heart failure with preserved ejection fraction.
Hieda M; Howden E; Shibata S; Tarumi T; Lawley J; Hearon CM; Palmer D; Fu Q; Zhang R; Sarma S; Levine BD
J Appl Physiol (1985); 2018 Jan; 124(1):76-82. PubMed ID: 29051333
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin (1-7) and Apelin co-therapy: New strategy for heart failure treatment of rats.
Soltani Hekmat A; Javanmardi K; Tavassoli A; Gholampour Y
Anatol J Cardiol; 2020 Mar; 23(4):209-217. PubMed ID: 32235135
[TBL] [Abstract][Full Text] [Related]
18. Dapagliflozin improves left ventricular remodeling and aorta sympathetic tone in a pig model of heart failure with preserved ejection fraction.
Zhang N; Feng B; Ma X; Sun K; Xu G; Zhou Y
Cardiovasc Diabetol; 2019 Aug; 18(1):107. PubMed ID: 31429767
[TBL] [Abstract][Full Text] [Related]
19. Reversal of angiotensin-(1-12)-caused positive modulation on left ventricular contractile performance in heart failure: Assessment by pressure-volume analysis.
Li T; Zhang Z; Zhang X; Chen Z; Cheng HJ; Ahmad S; Ferrario CM; Cheng CP
Int J Cardiol; 2020 Feb; 301():135-141. PubMed ID: 31521437
[TBL] [Abstract][Full Text] [Related]
20. Allicin ameliorates cardiac hypertrophy and fibrosis through enhancing of Nrf2 antioxidant signaling pathways.
Li XH; Li CY; Xiang ZG; Hu JJ; Lu JM; Tian RB; Jia W
Cardiovasc Drugs Ther; 2012 Dec; 26(6):457-65. PubMed ID: 22990325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
